Investor Connect Podcast

Hello, this is Hall T. Martin with the Startup Funding Espresso -- your daily shot of startup funding and investing.

The process of raising funding brings the startup founder several intangible benefits.

Here is a short list:

Fundraising forces you to think through your business strategy and articulate it clearly.

Investors will challenge your strategy requiring the founder to defend it.

The pitch elicits feedback from the investors which often improves the plan.

While entrepreneurs look at the opportunity in the deal, the investor looks at the risk.

Investors highlight the risks and the challenges to overcome.

This feedback sharpens the pitch.

Investors also provide feedback on the market, team, product, and other aspects that help refine the strategy.

The pitch presentation expands the circle of those who know the business and can potentially help in the future.

Consider the additional benefits that come from raising funding, which is a better business plan and a broader network of contacts.

Thank you for joining us for the Startup Funding Espresso where we help startups and investors connect for funding.

Let’s go startup something today.

For more episodes from Investor Connect, please visit the site at: 

Check out our other podcasts here: 
For Investors check out: 
For Startups check out: 
For eGuides check out: 
For upcoming Events, check out

For Feedback please contact  

Music courtesy of Bensound

Direct download: intangible_value_of_fundraising.mp3
Category:general -- posted at: 6:00am CDT

This is Investor Perspectives. I’m the host of Investor Connect, Hall T Martin, where we connect startups and investors for funding.

In our new Investor Perspectives series entitled “How to Solve the Biotech/Life Sciences Problem”, you’ll hear about growth in the biotech/life sciences segment.

As the COVID pandemic passes, we emerge into a new world. The biotech space is now undergoing tremendous change as we shift back to a normal way of life. The process for designing and approving vaccines demonstrated a new protocol. Biotech now moves into a new era. We have investors and startup founders describe the changes coming up.

Our guests are:

Yaniv Sneor, Co-founder, Mid Atlantic Bio Angels, 01:18
Carter Williams, CEO and Managing Partner, iSelect Fund, 05:05
Maximilian Bade, Founding Partner, Nucleus Capital, 07:35
Ron Paliwoda, President, Paliwoda Group, 10:34
Orrin Ailloni-Charas, Managing Partner, Global Health Impact Fund, 16:36
Eyal Lifschitz, Co-Founder and Managing Partner, Peregrine Ventures, 20:31
Mark Groper, Chief Executive Officer, Orion Biotechnology, 29:20

I hope you enjoy this episode.

For more episodes from Investor Connect, please visit the site at:       

Check out our other podcasts here: 
For Investors check out:  
For Startups check out:  
For eGuides check out:  
For upcoming Events, check out    

For Feedback please contact 

Music courtesy of Bensound.